CareDx
CDNA
trading on NASDAQ
since 2014
$11.82
(Δ -38.44%)
-$7.38 since open
CareDx provides innovative molecular diagnostic tests and monitoring solutions tailored for organ transplant recipients to optimize their health outcomes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $18.62 | $18.71 | $10.96 | $1.13B | 16.03M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.19 | n/a | 7.71 | -15.79% | -12.23% | 0% |